This article aims to provide an overview of GLP-1 based drugs, focusing on semaglutide (marketed as Ozempic for type 2 diabetes and as Wegovy for obesity) and tirzepatide (marketed as Mounjaro), which is a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 agonist
Glycogen synthase kinase-3 inhibitors: Rescuers of cognitive impairments
Combination Therapy When combined with phosphodiesterase inhibitors like sildenafil or tadalafil, PT-141 enhances blood flow, improves erectile function, and sustains arousal, particularly for patients with incomplete responses to conventional treatments (3)
Gordon extends this concept by arguing that trauma, chronic stress and PTSD-like symptom patterns may also reflect altered hypothalamic releasing factors and downstream hormone signaling, not just visible structural brain injury
Size and zeta potential measurements were conducted on a Malvern Zetasizer (Nano ZS, UK)